Zealand Pharma announces that Boehringer receives U.S. FDA Breakthrough Therapy designation and initiates two Phase III trials in MASH for survodutide

https://www.globenewswire.com/news-release/2024/10/08/2959436/0/en/Zealand-Pharma-announces-that-Boehringer-receives-U-S-FDA-Breakthrough-Therapy-designation-and-initiates-two-Phase-III-trials-in-MASH-for-survodutide.html

company announcement